Concepedia

Elango Subramoniapillai

ES

4

Publications

292

Citations

4

H-Index

2014

Active since

Affiliations

The University of Queensland(Current)

Royal Brisbane and Women's Hospital

QIMR Berghofer Medical Research Institute

Elango Subramoniapillai is an author at The University of Queensland specializing in cell transplantation, marrow transplantation, and transplantation.

Top concepts

Publications per year

2014–2021

4

Publications

4

Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial

Glen Kennedy, Antiopi Varelias, Slavica Vučković et al. · The Lancet Oncology · 2014 · 211 citations

, , +13

A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis

Glen Kennedy, Siok‐Keen Tey, Luke Buizen et al. · Blood · 2021 · 48 citations · Full text

Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation

Andrea Henden, Antiopi Varelias, Justine Leach et al. · Blood Advances · 2019 · 20 citations · Full text

Successful use of oseltamivir prophylaxis in managing a nosocomial outbreak of influenza A in a hematology and allogeneic stem cell transplant unit

Mimi Yue, Joel Collins, Elango Subramoniapillai et al. · Asia-Pacific Journal of Clinical Oncology · 2016 · 13 citations

Rows per page

1–4 of 4